MarkWide Research

Sale!

Pulmonary Function Testing System Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2023-2030

Published Date: December, 2022
No of Pages: 164
Delivery Format: PDF+ Excel

$2,950.00

Pulmonary function testing (PFT) is a diagnostic procedure used to assess the health of the lungs. A PFT is often referred to as a spirometry test or a lung function test. It assesses lung function by determining the amount (volume) and/or rate (flow) of air that can be breathed in and expelled. A PFT result can be used to diagnose and monitor lung diseases.

PFTs are conducted using a specialised machine known as a spirometer. The patient sits in a chair and breathes through a mouthpiece attached to the spirometer. The spirometer measures the volume and rate of air breathed and exhaled. It takes roughly 10 minutes to finish the test.

PFTs are generally painless and well tolerated. During the test, however, some people may experience shortness of breath, dizziness, or anxiety.

PFTs are frequently used to diagnose and monitor lung disorders such as asthma, chronic obstructive pulmonary disease (COPD), and others. They can also be used to assess the condition of the lungs before and after surgery, as well as to assess the effectiveness of certain therapies, such as inhaled drugs.

PFTs are not flawless, and there are certain drawbacks to be aware of. PFTs, for example, may be inaccurate in patients who have very small lungs, such as newborns and young children. PFTs may also be influenced by factors such as anxiety, smoking, and recent exercise.

Despite these limitations, PFTs continue to be an important tool for identifying and monitoring lung diseases. Ask your doctor if you have any questions concerning PFTs.

-Market drivers for pulmonary function testing systems
Pulmonary function testing (PFT) is a diagnostic procedure used to determine how effectively the lungs are working. PFT findings can be used to identify and track lung diseases. PFT can also be used to assess the efficacy of lung disease treatment.

There are various types of pulmonary function tests, each evaluating a distinct element of lung function. Spirometry is the most common type of PFT, and it assesses how much air the lungs can expel in one breath. Lung volume measurements and gas exchange testing are two further types of PFT.

PFT is typically considered safe and well-tolerated. During the test, the most common side effect is shortness of breath.

A qualified pulmonary function technician will normally do PFT in a hospital or clinic setting. The test usually takes between 30 and 60 minutes to complete.

The rising prevalence of lung diseases such as COPD, asthma, and lung cancer is driving the global pulmonary function testing system market. Because older people are more prone to lung problems, the growing elderly population is also a key driver of market growth.Furthermore, rising awareness of PFT and its benefits is likely to drive market growth over the forecast period.

The pulmonary function testing system market is divided into product, application, end user, and region segments.

The market is divided into product categories such as spirometers, gas exchange systems, lung volume measurement systems, and others. Because of the high prevalence of COPD and asthma, the spirometers sector is likely to account for the highest proportion of the market.

The market is divided into three applications: diagnostics, treatments, and research. Because of the increased demand for PFT in the diagnosis of lung disorders, the diagnostics application category is likely to account for the greatest proportion of the market.

The market is divided into three segments based on end users: hospitals, clinics, and research laboratories. Because of the increasing number of PFT procedures conducted in hospitals, the hospital sector is likely to account for the greatest proportion of the market.

The market is divided into two regions based on geography: North America and Europe.

Market Challenges for Pulmonary Function Testing Systems
Pulmonary function testing is a diagnostic method used to determine how well the lungs work. The test assesses lung function, namely how much air the lungs can hold, how rapidly they can empty, and how well they exchange oxygen and carbon dioxide.

Pulmonary function testing is used to detect and manage lung diseases such as asthma, bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD). The test can also be used to track the course of a lung illness and assess the efficacy of treatment.

When performing pulmonary function testing, numerous issues must be considered. To begin, the test necessitates the use of specialist equipment, which can be costly and is not always readily available. Second, the test is sensitive to a variety of circumstances, including body position, breathing pattern, and exertion level, which can make obtaining reliable results difficult. Finally, some people may find the test uncomfortable, and those who are afraid of enclosed settings may experience anxiety or a panic attack.

-Market Potential for Pulmonary Function Testing Systems
Pulmonary function testing (PFT) is a diagnostic procedure used to determine how well the lungs work. A spirometry test is another name for a PFT. This test determines how much air the lungs can store, how rapidly they can empty, and how efficiently they can transfer air in and out.

PFTs are carried out with the aid of a spirometer, which is a device that measures the amount and rate of air inhaled and exhaled. The procedure is normally carried out in a doctor’s office or hospital.

PFTs are used to diagnose and track a wide range of lung disorders, including asthma, bronchitis, and emphysema. They can also be used to determine how well the lungs function after a lung transplant or if a person has lung disease.

PFTs are typically considered safe and well-tolerated. Shortness of breath is the most common side effect.

PFTs are an important diagnostic and management tool for lung diseases. If you have been referred for a PFT, ask your doctor any questions you may have regarding the procedure.

market segmentation of pulmonary function testing systems
Pulmonary function testing (PFT) is a diagnostic procedure used to assess the function of the lungs. A spirometry test is another name for a PFT. It is the most commonly used test for diagnosing lung diseases such as asthma, bronchitis, and emphysema. The test is also used to track the course of certain disorders and assess the efficacy of treatments.

PFTs are done with a spirometer, which measures how much air the lungs can expel in a short period of time. The procedure is often performed at a doctor’s office or a hospital outpatient department.

PFTs are classified into two types: spirometry and plethysmography. Spirometry determines how much air the lungs can expel in a short period of time. Plethysmography determines how much air the lungs can store.

PFTs are not painful, but they are unpleasant. Shortness of breath and chest tightness may occur as a result of the exam.

Insurance typically covers PFTs. Your doctor may recommend that you see a pulmonologist, a specialist who specialises in lung problems, for more testing and treatment.

Competitive Landscape of the Pulmonary Function Testing System Market
The global pulmonary function testing system market is predicted to grow rapidly in the next few years. This is due to the increasing prevalence of respiratory illnesses as well as increased awareness regarding early detection and treatment of these conditions.

Pulmonary function testing (PFT) is a diagnostic procedure used to assess how effectively the lungs work. It is used to diagnose and monitor a number of lung disorders, including asthma and COPD. The test determines how much air the lungs can store, how well they can flow air in and out, and how well they exchange oxygen and carbon dioxide.

The pulmonary function testing system market is quite competitive. GE Healthcare, Philips Healthcare, Siemens Healthcare, and others are among the market’s leading participants. To acquire a competitive advantage in the market, these companies are always developing and offering new items.

The increased prevalence of respiratory illnesses is the primary driver of the pulmonary function testing system market’s expansion. Furthermore, rising awareness regarding the need for early detection and treatment of various conditions is supporting market expansion. Furthermore, technical advancements in pulmonary function testing systems are a major driver of market expansion. However, the high cost of these systems is a major impediment to industry growth.

The global pulmonary function testing system market is divided into product type, application, end user, and geographic segments. The market is divided into product types such as spirometers, plethysmographs, gas exchange systems, and others. The market is divided into three applications: diagnostics, treatments, and research. The market is divided into hospitals, clinics, and others based on the end user.

The global pulmonary function testing system market is divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Because of the rising frequency of respiratory illnesses and increased awareness about early diagnosis and treatment, North America is likely to hold the largest share of the market. Because of this, Europe is likely to be the second largest market for pulmonary function testing systems.

Market Trends for Pulmonary Function Testing Systems
The global pulmonary function testing system market is predicted to be worth USD 1.03 billion in 2019 and to develop at a CAGR of 5.8% between 2020 and 2025. The increased prevalence of chronic respiratory disorders such as COPD, asthma, and cystic fibrosis, as well as the growing elderly population, are the primary drivers of market expansion.

The market is divided into three product categories: spirometers, body plethysmographs, and gas analysis systems. Because of the widespread usage of this product type in the diagnosis and monitoring of respiratory disorders, the spirometers sector is predicted to have the greatest market share in 2019.

The pulmonary function testing system market is divided into hospitals, clinics, and others based on end users. Because of the increasing number of admissions for respiratory disorders and the availability of advanced facilities and skilled personnel in these settings, hospitals are likely to be the greatest contributor to the market in 2019.

Philips Healthcare (Netherlands), GE Healthcare (US), Schiller AG (Switzerland), Cosmed (Italy), MESI spol. s r. o. (Czech Republic), nSpire Health (US), Vyaire Medical (US), Morgan Scientific (US), Buxco Electronics (US), and COSMED are the market leaders (Italy). To acquire a competitive advantage in the industry, these businesses are focusing on growing their product portfolio and geographical reach. In September 2019, Philips Healthcare, for example, released a new version of its Respironics V60 ventilator, which has additional capabilities to improve patient care.

The global pulmonary function testing system market is predicted to grow rapidly between 2020 and 2025, owing to the increasing prevalence of chronic respiratory disorders and the growing elderly population. To obtain a competitive advantage in the industry, the market’s leading players are focusing on extending their product portfolio and geographical reach.

Future Prospects for the Pulmonary Function Testing System Market
During the projected period of 2020–2025, the worldwide pulmonary function testing system market is expected to develop at a CAGR of roughly 6.2%.

Pulmonary function testing (PFT) is a diagnostic procedure used to assess the health of the lungs. PFT can be used to diagnose and track a number of lung disorders, including asthma, bronchitis, and emphysema. It can also be used to figure out what’s causing your shortness of breath.

PFT is typically performed with the aid of a spirometer, which is a device that measures the amount of air that the lungs can expel in a certain amount of time. The test is typically performed in a doctor’s office or the Pulmonary Function Laboratory of a hospital.

PFTs are classified into two types: spirometry and plethysmography. The most prevalent type of PFT is spirometry. It measures how much air the lungs can expel in a given amount of time. Plethysmography determines how much air the lungs can store.

PFT is a painless and safe test. The sole negative effect is that some patients may experience dizziness or lightheadedness following the test.

The global pulmonary function testing system market is divided into three categories: product type, end-user, and geography.

The market is divided into three product categories: spirometers, body plethysmographs, and peak flow meters. Spirometers are the most popular sort of PFT instrument, and they are used to measure how much air the lungs can expel in a given amount of time. Body plethysmographs are used to determine how much air the lungs can store. Peak flow metres are used to calculate the amount of air that leaves the lungs.

The market is divided into three end-user segments: hospitals, clinics, and home care. PFT devices are most commonly used in hospitals. PFT is often conducted in the pulmonary function laboratory of a hospital. Clinics are the second-most common users of PFT equipment. A PFT can be conducted in the office of a clinic or in the outpatient department of a hospital. Home

LIST OF KEY COMPANIES PROFILED:

    • NDD Medizintechnik AG (Switzerland)
    • COSMED srl (Italy)
    • MGC Diagnostics Corporation (U.S.)
    • PulmOne Advanced Medical Devices (Israel)
    • CHEST M.I., Inc. (Japan)
    • VYAIRE MEDICAL, INC. (U.S.)
    • KoKo PFT (U.S.)
    • Medical Electronic Construction (Belgium)

Report Scope & Segmentation

 

  ATTRIBUTE

 

DETAILS

 

Study Period

 

2018-2029

 

Base Year

 

2021

 

Estimated Year

 

2022

 

Forecast Period

 

 

2022-2029

 

 

Historical Period

 

 

2018-2020

 

 

Unit

 

 

Value (USD million)

 

 

Segmentation

 

 

By Type

    • Portable PFT Systems
    • Complete PFT Systems
 

By End-user

    • Hospitals
    • Physical Examination (Diagnostic) Centers
    • Physician Groups (Clinics)
    • Others
 

By Geography

    • North America (the U.S. and Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
    • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
    • Latin America (Brazil, Mexico, Rest of Latin America)
    • The Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa)
 

By Type

    • Portable PFT Systems
    • Complete PFT Systems
 

By End-user

    • Hospitals
    • Physical Examination (Diagnostic) Centers
    • Physician Groups (Clinics)
    • Others
    • ndd Medizintechnik AG (Switzerland)
    • COSMED srl (Italy)
    • MGC Diagnostics Corporation (U.S.)
    • PulmOne Advanced Medical Devices (Israel)
    • CHEST M.I., Inc. (Japan)
    • VYAIRE MEDICAL, INC. (U.S.)
    • KoKo PFT (U.S.)
    • Medical Electronic Construction (Belgium)

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF